Enteral Feeding Intolerance: Clinical Trials

2 trials for Enteral Feeding Intolerance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Enteral Feeding Intolerance: new trials by email Literature Review of Enteral Feeding Intolerance trials Research Report on Enteral Feeding Intolerance

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients
Prucalopride, Metoclopramide - Enteral Feeding Intolerance
Phase 1 / Phase 2CompletedAin Shams University702022-08-302024-04-12
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
TD-8954, Metoclopramide - Enteral Feeding Intolerance
Phase 1 / Phase 2CompletedTakeda132014-01-012020-02-18

Interventions

Metoclopramide (2)  ·  4-((4-((2-isopropyl-1H-benzoimidazole-4-carbonyl)amino)methyl)piperidin-1-ylmethyl)piperidine-1-carboxylic acid methyl ester (1)  ·  prucalopride (1)

Sponsors

Ain Shams University (1)  ·  Takeda (1)

Countries

Australia (1)  ·  Egypt (1)

Top investigators

Daniel Canafax, PharmD, FCCP (1)  ·  Eman Elmokadem, PhD (1)

Results publications

PMID 31990087, PMID 39584139